This website concerns the proposed settlement of a stockholder class action which relates to the merger transaction (the "Merger") by which Nutraceutical International Corporation ("Nutraceutical") was acquired by HGGC Fund III, L.P., an investment fund of the private equity firm HGGC, LLC. The Merger closed on August 23, 2017.

The parties have reached a proposed settlement of the Action for $17,500,000 in cash (the "Settlement") that resolves all claims in the Action. On June 15, 2021, the Court held a hearing on the Settlement and related matters. Following the hearing, the Court entered an Order and Final Judgment finally approving the Settlement, approving the Plan of Allocation for the proceeds of the Settlement, and awarding attorney's fees and litigation expenses to Plaintiffs' Counsel.

If you are a member of the Settlement Class, your rights will be affected and you may be eligible for a payment from the Settlement. The Settlement Class consists of:

All former record holders and beneficial owners of Nutraceutical common stock who held or owned that stock at any time during the period beginning on and including May 22, 2017 through and including August 23, 2017 (the date of the closing of the Merger) (the "Class Period"), regardless of when they bought or sold their stock, including any and all of their respective successors or assigns, excluding certain persons and entities who are excluded from the Settlement Class by definition as set forth in the Notice (see paragraph 19 of the Notice).

Eligible Class Members do not need to submit a claim form in order to receive a distribution from the Settlement. Your distribution from the Settlement will be paid to you directly.

Please be patient, as it will take some time to conduct the Settlement distribution.

Please read the Notice carefully.  If you have questions, you may call the Nutraceutical Stockholder Litigation Help Line at 877-777-9482 or email info@NutraceuticalStockholderLitigation.com.